News

While Karl Fischer (KF) titration is known as the champion of battery manufacturing quality control, techniques such as ...
A real-world study supports cenobamate as an effective option for patients with drug-resistant epilepsy even after multiple ...
BioMarin Pharmaceutical Inc. today announced that the Phase 3 PEGASUS trial evaluating PALYNZIQ® (pegvaliase-pqpz) met its primary efficacy endpoint, demonstrating a statistically significant lowering ...
Rapport Therapeutics focuses on developing specific small molecule therapies for CNS diseases. Check out my recommendation ...
Travere Therapeutics, Inc., today announced that the Company will present three abstracts, including one late-breaking oral presentation, at the upcoming National Kidney Foundation (NKF) Spring ...
A key objective of ongoing research rooted in molecular physics is to understand and precisely control chemical reactions at ...